Status:
COMPLETED
Intervention With n-3 Polyunsaturated Fatty Acids (PUFA)-Supplemented Products in Moderate Hypertriglyceridemic Patients
Lead Sponsor:
University of Jena
Conditions:
Hypertriglyceridemia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The study was performed to investigate the effects of a daily consumption of n-3 PUFA supplemented products (sausage, bread rolls, wafers, milk beverage) on cardiovascular risk factors in hypertriglyc...
Detailed Description
Recent studies suggest that n-3 LC-PUFA intake might be useful to prevent coronary heart diseases. As a precondition for participating in this study, the patients were provided information in writing...
Eligibility Criteria
Inclusion
- TAG values ≥ 150 mg/dl or ≥ 1.7 mmol/L
Exclusion
- Lipid lowering medications
- Glucocorticoids
- Gastrointestinal or metabolic diseases (e.g., diabetes mellitus, hyperthyroidism or hypothyroidism, hypercholesteremic patients with familial previous impacts)
- Daily alcohol abuse
- Taking dietary supplements (e. g., fish oil capsules, vitamin E)
- Known allergies or foodstuff indigestibility
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01437930
Start Date
September 1 2011
End Date
April 1 2012
Last Update
July 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Friedrich Schiller University, Institute of Nutrition
Jena, Germany, 07743